The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.86, Iss.9, 2008-09, pp. : 1025-1032

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD133 silencing inhibits stemness properties and enhances chemoradiosensitivity in CD133-positive liver cancer stem cells

International Journal of Molecular Medicine, Vol. 31, Iss. 2, 2013-01 ,pp. : 315-324

Spandidos Publications

Access to resources Recommend Favorite

Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133⁺ endothelial progenitor cells for cardiac repair

By Rufaihah Abdul Jalil Haider Husnain Khawaja Heng Boon Chin Ye Lei Tan Ru San Toh Wei Seong Tian Xian Feng Sim Eugene Kwang-Wei Cao Tong

Regenerative Medicine, Vol. 5, Iss. 2, 2010-03 ,pp. : 231-244

Future Medicine

Access to resources Recommend Favorite

Coexpression of CD44‐positive/CD133‐positive cancer stem cells and CD204‐positive tumor‐associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2766-2777

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prominin-1 (CD133): from progenitor cells to human diseases

By Fargeas Christine A Fonseca Ana-Violeta Huttner Wieland B Corbeil Denis

Future Lipidology, Vol. 1, Iss. 2, 2006-04 ,pp. : 213-225

Future Medicine

Access to resources Recommend Favorite